BUCCOLIERO, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 251
EU - Europa 97
AS - Asia 29
SA - Sud America 1
Totale 378
Nazione #
US - Stati Uniti d'America 251
IT - Italia 32
IE - Irlanda 28
SE - Svezia 16
HK - Hong Kong 13
FI - Finlandia 6
GB - Regno Unito 6
JO - Giordania 6
SG - Singapore 6
DE - Germania 4
BE - Belgio 2
BR - Brasile 1
CH - Svizzera 1
CN - Cina 1
IN - India 1
KR - Corea 1
NL - Olanda 1
RU - Federazione Russa 1
TR - Turchia 1
Totale 378
Città #
Fairfield 33
Chandler 29
Dublin 28
Ashburn 24
Ann Arbor 15
Cambridge 14
Houston 13
Woodbridge 13
Florence 12
Lawrence 12
Seattle 12
Altamura 11
Boardman 7
Medford 7
Hong Kong 6
New York 6
Princeton 6
Wilmington 6
Jacksonville 4
Singapore 4
Brussels 2
Falls Church 2
San Diego 2
Scandicci 2
Andover 1
Bern 1
Boston 1
Bremen 1
Grevenbroich 1
Hanover 1
Islington 1
Izmir 1
London 1
Porto Alegre 1
Prescot 1
Pune 1
Seoul 1
Shanghai 1
Washington 1
Totale 285
Nome #
COUP-TFII in pancreatic adenocarcinoma: Clinical implication for patient survival and tumor progression. 122
Telomerase Activated Thymidine Analogue Pro-drug Is A New Molecule Targeting Hepatocellular Carcinoma 64
Thiazolidinediones inhibit hepatocarcinogenesis in hepatitis B virus-transgenic mice by peroxisome proliferator-activated receptor gamma-independent regulation of nucleophosmin. 62
Pontin52 Is A Ppargamma Target Gene and Its Knockdown Reduces Hepatic Cancer In An Orthotopic-singenic Mouse Model 41
Rosiglitazone reduces the in vitro and in vivo growth of HCC cell lines through a PPARgamma-independent inhibition of Ruvbl-1 35
Therapeutic effects of a telomerase activated pro-drug, acycloguanosyl 5 '-thymidyltriphosphate, in hepatocellular carcinoma 34
ANTAGONISTIC SIGNALLING BY PPARGAMMA AND ROSIGLITAZONE CONVERGE ON RUVBL1 REGULATION IN HCC CELLS 22
Totale 380
Categoria #
all - tutte 1.507
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.507


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202057 8 4 0 6 6 7 7 6 6 4 2 1
2020/202125 7 1 1 2 1 2 1 1 3 3 3 0
2021/202235 1 5 0 5 1 1 2 1 2 1 2 14
2022/2023131 11 27 6 10 13 18 18 5 18 0 4 1
2023/202457 9 2 7 5 8 10 0 6 0 1 7 2
2024/202511 11 0 0 0 0 0 0 0 0 0 0 0
Totale 380